Çetin, M. 2022. FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW. International Journal of PharmATA , vol.2, no.4 , 70-80.

Çetin, M., (2022). FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW. International Journal of PharmATA , vol.2, no.4, 70-80.

Çetin, Meltem. "FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW," International Journal of PharmATA , vol.2, no.4, 70-80, 2022

Çetin, Meltem. "FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW." International Journal of PharmATA , vol.2, no.4, pp.70-80, 2022

Çetin, M. (2022) . "FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW." International Journal of PharmATA , vol.2, no.4, pp.70-80.

@article{article, author={Meltem ÇETİN}, title={FIXED-DOSE COMBINATION-ORALLY DISINTEGRATING TABLET (FDC-ODT) STUDIES FOR THE TREATMENT OF TYPE 2 DIABETES OR CARDIOVASCULAR DISEASES-A MINI REVIEW}, journal={International Journal of PharmATA}, year=2022, pages={70-80} }